ROI-NJ

Anastasia Harrison, owner of architecture and design studio AHD & Co, is introducing Heirloom, a bespoke home concept store in downtown Westfield. The store is located below the AHD&Co offices at 112 Elm Street, the main artery for Westfield business. The store offers a selection of customizable furnishings, lighting, antiques, rugs, art, linens, and home gifts. Brands range from Currey & Company to Vanguard. Heirloom said it plans “seasonal vignettes that display its offerings in styled living environments to help customers effortlessly visualize their designs.”

A general and cosmetic dentistry practice is locating in Montvale, bolstering the presence of health care firms in the northern Bergen County town. Kallos Dental signed a long-term lease for 3,100 square feet at 160 Summit Avenue. The practice is opening in May 2025. The property is managed by Accordia, a Fairfield-based real estate firm.

As new technologies such as artificial intelligence (AI), crypto and blockchain take center stage across the Garden State, the New Jersey Innovation and Technology Alliance (NJITA) has launched a program to “take away the fear and mystification” created by emerging technologies by connecting the tech community with policymakers to help shape policies that support innovation, economic development, and the tech sector. Led by Executive Director Carlos Iván Merino, NJITA aims to educate stakeholders, policymakers and consumers about the benefits that these new technologies represent and the important role they will play in New Jersey’s future. Read more:

NAI DiLeo-Bram & Co. has promoted Marc Shein to executive vice president, recognizing his leadership in New Jersey’s commercial real estate sector. Shein has been one of the firm’s top three producers for the past three years and has played a key role in the company’s growth across industrial, office, retail and land transactions. “Marc’s collaborative style and client-first focus have made a major impact on our firm,” said David A. Simon, chief operating officer of NAI DiLeo-Bram & Co.

Downtown Morristown is serving up more than great food this spring — it’s serving opportunity. From April 21–25, Morristown Restaurant Week returns with 30-plus local restaurants offering special menus and promotions designed to boost foot traffic and sales across the central business district. New for 2025: a ticketed tasting crawl called Snack, Sip & Stroll, running April 21–23. Each evening, diners will rotate through 3 to 4 restaurants, enjoying curated bites, drinks, and desserts.

Happy 50th birthday, Microsoft! From a scrappy startup in Albuquerque to the tech giant that made Windows, Word, and "Reply All" a part of our daily lives! Thanks for turning our company cubicles —and home offices —into 24/7 workspaces. — ROI-NJ!

MJ Unpacked, a cannabis industry trade event with exclusive attendance for licensed operators, brands, and investors, will tackle a range of industry concerns, challenges and opportunities at its upcoming three-day event at the Hard Rock Hotel & Casino Atlantic City, on April 29 – May 1.

The Hain Celestial Group, which makes healthful snacks such as Garden Veggie Snacks, Terra chips, and Joya and Natumi plant-based beverages, is expanding its presence in the marketplace with one of its offerings appearing in Dollar General stores. In late March, the Hoboken-based company’s Garden Veggie Straws in Sea Salt started taking their place on shelves at Dollar General stores, with the rollout to more than 20,000 neighborhood general stores nationwide expected to be completed later this month.

Op-Ed | Morristown Medical Center expansion means high quality health care benefits all, writes Meghan Hunscher, Morris County Chamber of Commerce:

Johnson & Johnson Thursday announced it has completed its acquisition of Intra-Cellular Therapies. Intra-Cellular Therapies is now part of Johnson & Johnson and will operate as a business unit within Johnson & Johnson Innovative Medicine. With this acquisition, Johnson & Johnson adds CAPLYTA (lumateperone) to its robust portfolio of differentiated medicines. CAPLYTA is a once-daily oral therapy approved to treat adults with schizophrenia, as well as the first and only U.S. Food and Drug Administration (FDA)-approved treatment for depressive episodes associated with bipolar I or II disorder (bipolar depression), as a monotherapy and adjunctive therapy with lithium or valproate. “At Johnson & Johnson, we are committed to transforming care for the millions of people worldwide living with neuropsychiatric and neurodegenerative disorders,” said Joaquin Duato, Chairman and CEO, Johnson & Johnson.